Senior Director, HEOR - Acoramidis (Global Lead)

Senior Director, HEOR – Acoramidis (Global Lead) Mavericks Wanted When was the last time you achieved the impossible? If that thought feels overwhelming, you might want to pause here, but if it sparks excitement…read on. In 2015, we pioneered a “moneyball for biotech” approach, pooling projects and promising early‑stage research from academia together under one financial umbrella to reduce risk and unleash innovation. This model allows science and small teams of experts to lead the way. We build bridges to groundbreaking advancements in rare disease, and develop life‑changing medicines for patients with unmet needs as fast as humanly possible. Together we define white space, push boundaries, and empower people to solve problems. If you're someone who defies convention, join us and work alongside some of the most respected minds in the industry. Together, we'll ask “why not?” and help reengineer the future of biopharma. At BridgeBio, we value curiosity and experimentation—including the ethical & thoughtful use of AI to improve clarity, speed, and quality of work. What You’ll Do BridgeBio is seeking a highly strategic and execution‑oriented HEOR leader to define and drive the global evidence strategy for acoramidis in ATTR‑CM. This individual will play a pivotal role in enabling successful global launch, optimizing payer access, and sustaining long‑term product differentiation in an increasingly competitive and evolving landscape. As the global HEOR lead, this role will shape the evidence generation agenda across the product lifecycle—spanning clinical development, launch, and post‑marketing—leveraging real‑world evidence (RWE), comparative effectiveness research, and patient‑centered outcomes. The leader will serve as a key partner to Market Access, Medical Affairs, Clinical Development, and Commercial teams to ensure evidence translates into impactful value narratives for payers and HTA bodies worldwide. Key Responsibilities Global HEOR Strategy: Define and lead the end‑to‑end global HEOR strategy for acoramidis across launch and lifecycle, ensuring alignment with clinical, regulatory, and commercial objectives and driving evidence‑based decision‑making. Evidence Generation & Data Strategy: Design and oversee innovative RWE, economic models, and data partnerships (e.g., claims, EHR, observational survey datasets) to support value demonstration and long‑term evidence generation. Payer & HTA Readiness: Develop robust, payer‑relevant evidence packages and lead HEOR contributions to global HTA submissions, pricing, reimbursement, and access strategies. Publications & Scientific Dissemination: Lead the HEOR publication strategy, including congress planning and peer‑reviewed publications, to establish a compelling evidence narrative. Patient‑Centered Outcomes: Drive the development and integration of PROs and other patient‑centered endpoints to demonstrate meaningful clinical benefit and differentiation. Competitive Intelligence & Positioning: Proactively assess and anticipate competitive dynamics (including generics, pipeline entrants, and alternative therapies) to inform evidence strategy and positioning. Cross‑Functional Leadership: Partner closely with Market Access, Medical Affairs, Clinical, Regulatory, and Commercial teams to ensure cohesive and actionable evidence strategies. Governance & Scientific Integrity: Ensure HEOR activities are conducted with scientific rigor and appropriate governance, maintaining independence of evidence generation while enabling compliant, impactful use. External Engagement: Oversee external vendors, research partners, and academic collaborations to deliver high‑quality, timely evidence outputs. Where You’ll Work This is an onsite role and requires in‑office collaboration 2–3x per week in our San Francisco and Palo Alto offices. Who You Are Advanced degree (PhD, PharmD, MPH, MD, or equivalent) in health economics, outcomes research, epidemiology, or related field. 10+ years of progressive HEOR experience within biopharma or consulting, including leadership of global programs. Demonstrated experience supporting product launches and payer strategy development in specialty or rare diseases preferred. Strong understanding of global HTA frameworks (e.g., NICE, ICER, CADTH, G‑BA) and payer evidence requirements. Proven track record in RWE, economic modeling, and PRO strategy development. Strategic, enterprise‑level thinker with strong business acumen. Ability to translate complex evidence into clear, compelling value narratives for diverse stakeholders. Influential cross‑functional leader with a collaborative and proactive mindset. Strong project leadership and ability to manage multiple priorities in a fast‑paced environment. Executive presence with excellent communication and stakeholder engagement skills. Salary & Benefits BridgeBio offers a market‑competitive total rewards package, including base pay, an annual performance bonus, company equity, and generous health benefits. Salary range for California: $270,000 – $375,000 USD Benefits Highlights Market‑leading compensation 401(k) with employer match Employee Stock Purchase Program (ESPP) Pre‑tax commuter benefits (transit and parking) Referral bonus for hired candidates Subsidized lunch and parking on in‑office days 100% employer‑paid medical, dental, and vision premiums for you and your dependents Health Savings Account (HSA) with annual employer contributions, plus Flexible Spending Accounts (FSA) Fertility & family‑forming benefits Expanded mental health support (therapy and coaching resources) Hybrid work model with flexibility Flexible, “take‑what‑you‑need” paid time off and company‑paid holidays Comprehensive paid medical and parental leave Career Development Opportunities for skill development and internal mobility across discovery, clinical trials, and FDA pipelines. Career pathing through regular feedback, continuous education, and professional development programs via LinkedIn Learning, LifeLabs, and BetterUp coaching. Performance recognition with financial rewards, peer‑to‑peer recognition, and growth opportunities. #J-18808-Ljbffr BridgeBio